Tearsheet

Aveanna Healthcare (AVAH)


Market Price (12/30/2025): $8.35 | Market Cap: $1.7 Bil
Sector: Health Care | Industry: Health Care Facilities

Aveanna Healthcare (AVAH)


Market Price (12/30/2025): $8.35
Market Cap: $1.7 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.


0 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Chronic Disease Management, Show more.
Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 69%
1  Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 58%
2  Key risks
AVAH key risks include [1] margin pressure on its core Private Duty Services segment from persistent labor shortages and wage inflation and [2] significant interest rate exposure due to its substantial variable-rate debt.
0 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Chronic Disease Management, Show more.
1 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 69%
2 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 58%
3 Key risks
AVAH key risks include [1] margin pressure on its core Private Duty Services segment from persistent labor shortages and wage inflation and [2] significant interest rate exposure due to its substantial variable-rate debt.

Valuation, Metrics & Events

AVAH Stock


Why The Stock Moved


Qualitative Assessment

AI Analysis | Feedback

Aveanna Healthcare (AVAH) experienced a 4.5% stock movement between August 31, 2025, and December 30, 2025, influenced by a combination of positive financial performance, strategic developments, and shifts in investor sentiment. The key points contributing to this movement include:

1. Analyst Upgrades and Price Target Increases.

Throughout August and September 2025, several prominent analyst firms upgraded Aveanna Healthcare's stock ratings and significantly raised their price targets. Notably, on September 18, 2025, JP Morgan upgraded AVAH from 'Underweight' to 'Neutral' and increased its price target from $6.00 to $10.00. This followed earlier upgrades in August from Barclays (to 'Overweight', target $9.50) and UBS (to 'Neutral', target $8.00), as well as Raymond James (to 'Outperform', target $9.00). These positive revisions by analysts generally signal increased confidence in the company's future performance and can contribute to upward stock momentum.

2. Strong Third Quarter 2025 Financial Results.

On November 6, 2025, Aveanna Healthcare announced its third-quarter 2025 earnings, which substantially exceeded analyst expectations. The company reported an earnings per share (EPS) of $0.15, notably higher than the forecasted $0.0792, and revenue of $622 million, surpassing the projected $578.51 million. Additionally, Aveanna raised its full-year 2025 revenue guidance to greater than $2.375 billion and adjusted EBITDA guidance to greater than $300 million, indicating a positive outlook for its operational performance.

Show more

Stock Movement Drivers

Fundamental Drivers

The -5.7% change in AVAH stock from 9/29/2025 to 12/29/2025 was primarily driven by a -75.9% change in the company's P/E Multiple.
929202512292025Change
Stock Price ($)8.878.36-5.75%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)2177.672290.595.19%
Net Income Margin (%)0.85%3.29%286.64%
P/E Multiple96.0723.15-75.91%
Shares Outstanding (Mil)200.97208.95-3.97%
Cumulative Contribution-5.90%

LTM = Last Twelve Months as of date shown

Market Drivers

9/29/2025 to 12/29/2025
ReturnCorrelation
AVAH-5.7% 
Market (SPY)3.6%45.6%
Sector (XLV)14.7%14.9%

Fundamental Drivers

The 59.8% change in AVAH stock from 6/30/2025 to 12/29/2025 was primarily driven by a 1168.5% change in the company's Net Income Margin (%).
630202512292025Change
Stock Price ($)5.238.3659.85%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)2093.082290.599.44%
Net Income Margin (%)0.26%3.29%1168.49%
P/E Multiple187.2923.15-87.64%
Shares Outstanding (Mil)194.67208.95-7.33%
Cumulative Contribution58.99%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2025 to 12/29/2025
ReturnCorrelation
AVAH59.8% 
Market (SPY)11.6%19.2%
Sector (XLV)16.1%-1.6%

Fundamental Drivers

The 79.4% change in AVAH stock from 12/29/2024 to 12/29/2025 was primarily driven by a 67.9% change in the company's P/S Multiple.
1229202412292025Change
Stock Price ($)4.668.3679.40%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)1983.472290.5915.48%
P/S Multiple0.450.7667.87%
Shares Outstanding (Mil)193.36208.95-8.06%
Cumulative Contribution78.23%

LTM = Last Twelve Months as of date shown

Market Drivers

12/29/2024 to 12/29/2025
ReturnCorrelation
AVAH79.4% 
Market (SPY)16.6%21.4%
Sector (XLV)13.6%10.7%

Fundamental Drivers

The 971.8% change in AVAH stock from 12/30/2022 to 12/29/2025 was primarily driven by a 819.6% change in the company's P/S Multiple.
1230202212292025Change
Stock Price ($)0.788.36971.79%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)1750.572290.5930.85%
P/S Multiple0.080.76819.61%
Shares Outstanding (Mil)186.11208.95-12.27%
Cumulative Contribution955.66%

LTM = Last Twelve Months as of date shown

Market Drivers

12/30/2023 to 12/29/2025
ReturnCorrelation
AVAH211.9% 
Market (SPY)47.9%30.7%
Sector (XLV)17.6%21.8%

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
AVAH Return--36%-89%244%71%89%-25%
Peers Return16%38%-12%21%26%16%151%
S&P 500 Return16%27%-19%24%23%17%114%

Monthly Win Rates [3]
AVAH Win Rate-33%17%50%58%58% 
Peers Win Rate52%65%42%68%57%52% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
AVAH Max Drawdown--47%-91%-9%-19%-19% 
Peers Max Drawdown-34%-5%-26%-7%-9%-23% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/29/2025 (YTD)

How Low Can It Go

Unique KeyEventAVAHS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-94.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1807.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days

Compare to HPQ, HPE, IBM, CSCO, AAPL

In The Past

Aveanna Healthcare's stock fell -94.8% during the 2022 Inflation Shock from a high on 6/14/2021. A -94.8% loss requires a 1807.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Aveanna Healthcare (AVAH)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AI Analysis | Feedback

HCA Healthcare for home healthcare.

Like a children's hospital that provides continuous, specialized medical care directly in the patient's home.

A skilled nursing facility (SNF) that delivers comprehensive medical, therapeutic, and hospice services to patients in their own homes.

AI Analysis | Feedback

```html
  • Private Duty Nursing: Provides skilled nursing care for medically fragile children and adults in their homes.
  • Home Health: Offers skilled nursing, therapy services, and home health aide assistance for adult patients recovering from illness, injury, or surgery.
  • Hospice Care: Delivers compassionate end-of-life care focusing on comfort, dignity, and support for patients and their families.
  • Medical Solutions (DME/HME): Supplies durable medical equipment and supplies, including enteral nutrition, respiratory services, and incontinence products.
```

AI Analysis | Feedback

Major Customers of Aveanna Healthcare (AVAH)

Aveanna Healthcare (AVAH) primarily serves individual patients in their homes. While the company's services are largely reimbursed by government programs (like Medicaid and Medicare) and commercial insurance companies, the direct recipients and beneficiaries of their care are individuals and their families.

Based on its service lines, Aveanna Healthcare serves the following categories of customers:

  • Medically Fragile Children and Young Adults: This category primarily includes pediatric and young adult patients with complex medical needs requiring continuous private duty nursing care in their homes. These individuals often have chronic conditions, developmental disabilities, or technology dependencies that necessitate high-acuity care.
  • Adult Patients Requiring Skilled Home Health and Hospice Care: This category encompasses adult patients, often seniors, who need skilled nursing, therapy (physical, occupational, speech), or medical social services following a hospital stay, for chronic illness management, or for end-of-life hospice care in their homes.
  • Patients Requiring Home Medical Equipment, Supplies, and Nutritional Solutions: This category includes patients of all ages who need durable medical equipment (e.g., respiratory equipment, wheelchairs), various medical supplies (e.g., wound care, incontinence products), and enteral nutrition solutions for their care at home. This often complements their other home care services.

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

Jeff Shaner, President and Chief Executive Officer

Jeff Shaner was appointed President and Chief Executive Officer of Aveanna Healthcare in January 2023. He also serves on the Board of Directors. Mr. Shaner is responsible for overseeing the company's three operating divisions: private duty services, medical solutions, and home health and hospice. He has been integral to the formation of Aveanna Healthcare and its strategy to become a leading national provider of homecare. Mr. Shaner brings over 20 years of experience in post-acute healthcare leadership. He began his career in 2000 leading operations at Total Care, Inc. After Total Care was acquired by The Healthfield Group, he led the integration of eight acquired companies into Healthfield, which was subsequently sold to Gentiva Health Services, Inc. in 2006. Following Healthfield's merger with Gentiva, Mr. Shaner held various leadership roles at Gentiva, including President of the Hospice division. After Gentiva's sale to Kindred Healthcare in 2015, Mr. Shaner provided consulting services to Linden Capital Partners and Blue Wolf Capital on post-acute investment opportunities. He joined PSA Healthcare as Chief Operating Officer in 2015 and was instrumental in the formation of Aveanna Healthcare in 2017, a company which is owned by Bain Capital Private Equity and J.H. Whitney Capital Partners.

Matt Buckhalter, Chief Financial Officer and Principal Financial Officer

Matt Buckhalter has more than a decade of financial leadership experience in the healthcare industry. He joined Aveanna in 2016 and is responsible for corporate and operational finance, business intelligence, financial planning and analysis (FP&A), and investor relations. Prior to his current role, Mr. Buckhalter served as Senior Vice President of Finance and led the company's Investor Relations Group. Before joining Aveanna, he was Vice President of Finance for RT Capital and served as a senior financial analyst for Gentiva Health Services. He was appointed Chief Financial Officer, effective January 1, 2024, after serving as Interim Chief Financial Officer and Principal Financial Officer since July 2023.

Rod Windley, Chairman of the Board

Rod Windley has a long and distinguished career in the healthcare industry. He currently serves as Chairman of the Board of Aveanna Healthcare. In 1989, Mr. Windley founded The Healthfield Group, where he served as Chairman and Chief Executive Officer. Healthfield merged with Gentiva Health Services in 2009, and Mr. Windley served as Vice Chairman and later Executive Chairman of Gentiva. Under his leadership, the combined companies grew to over $2 billion in annual revenue. In 2015, he helped guide Gentiva through its merger with Kindred Healthcare, which became the largest sale of homecare assets in the nation's history. Prior to the formation of Aveanna in 2017, Mr. Windley served as Executive Chairman of PSA Healthcare. Aveanna was formed through the merger of Epic Health Services and PSA Healthcare and is owned by private equity firms Bain Capital Private Equity and J.H. Whitney Capital Partners, among other investors. He is a founding member of the National Association for Home Care and Hospice (NAHC).

Kristy Rohwedder, Chief Operating Officer

Kristy Rohwedder oversees both the Private Duty Services Division and the Medical Solutions Division at Aveanna. Prior to joining Aveanna Healthcare, Kristy was the Chief Executive Officer of Florida Autism Center/Fusion Autism Center, where she led rapid expansion efforts. She later served as Chief Operating Officer at BlueSprig Pediatrics after the company was acquired. Ms. Rohwedder also brings extensive experience from her fourteen years at PSA Healthcare, where she held a variety of roles. At Aveanna, she has held key leadership positions, including President of Private Duty Nursing.

Jerry Perchik, Chief Legal Officer and Secretary

Jerry Perchik serves as Aveanna's Chief Legal Officer and Secretary, acting as the primary legal advisor to the Chief Executive Officer, the senior management team, and the Board of Directors. He has over fifteen years of experience in corporate law and the healthcare industry. Before joining Aveanna, Mr. Perchik most recently served as Chief Legal Officer for MedQuest Associates. He has also previously held various corporate leadership roles and legal capacities for both publicly traded and private equity-sponsored healthcare companies.

```

AI Analysis | Feedback

Key Risks to Aveanna Healthcare (AVAH)

Aveanna Healthcare (AVAH) faces several critical risks to its business operations and financial outlook, with the most significant challenges stemming from labor market dynamics and government reimbursement policies.

  1. Labor Shortages and Wage Inflation: The most significant risk to Aveanna Healthcare is the ongoing challenge of labor shortages, particularly in nursing, coupled with wage inflation. This persistently pressures the margins of the company's core Private Duty Services segment. The company's ability to offer competitive pay to caregivers is heavily dependent on Medicaid rate negotiations, making reimbursement uncertain in key states.
  2. Medicaid and Medicare Rate Uncertainty and Regulatory Risks: Aveanna Healthcare generates a substantial portion of its revenue from government programs, with 23% from Medicaid and 10% from Medicare as of the first quarter of 2025. Therefore, reductions in Medicare and Medicaid rates, changes in payment methods, or broader regulatory shifts in healthcare laws could materially and adversely affect the company's revenue stability and profitability.
  3. High Variable-Rate Debt and Interest Rate Risk: Aveanna Healthcare is exposed to significant interest rate risk due to its substantial variable-rate debt. This debt structure could lead to increased borrowing costs and strain financial flexibility, especially if industry or macroeconomic conditions worsen, or if interest rates continue to rise.

AI Analysis | Feedback

The clear emerging threat for Aveanna Healthcare (AVAH) is the aggressive consolidation and integration of home healthcare services by large, technologically advanced healthcare conglomerates and payers, such as UnitedHealth Group's Optum and CVS Health.

These entities possess significant capital, existing patient populations, and robust technological infrastructure. By acquiring major home health providers (e.g., Optum's acquisitions of LHC Group and Amedisys, which are direct competitors to Aveanna), these conglomerates are building highly integrated, data-driven, and efficient care delivery networks that span insurance, pharmacy, primary care, and home care. This strategy allows them to achieve economies of scale, leverage advanced analytics for better outcomes, and offer more comprehensive and potentially lower-cost solutions to patients and payers. This trend directly threatens Aveanna's ability to compete on scale, technology, pricing, and access to patient populations as a standalone provider, mirroring the disruption of traditional businesses by new, integrated, and technologically superior models.

AI Analysis | Feedback

Aveanna Healthcare (AVAH) operates in several key segments within the home healthcare market, primarily in the United States. The addressable markets for their main products and services are as follows:

  • Private Duty Services (PDS)
    • U.S. Pediatric Home Healthcare: The U.S. pediatric home healthcare market size was estimated at approximately USD 13.50 billion in 2024, with projections to reach USD 21.24 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.85% from 2024 to 2030. Another estimate placed the U.S. pediatric home healthcare market at USD 20.1 billion in 2024, anticipated to grow at a CAGR of 6.5% between 2025 and 2034.
    • U.S. Private Nursing Services (including adult and pediatric): The U.S. private nursing services market generated a revenue of approximately USD 1.84 billion in 2023 and is expected to reach USD 2.69 billion by 2030, with a CAGR of 5.6% from 2024 to 2030.
  • Home Health & Hospice (HHH)
    • U.S. Home Healthcare: The U.S. home healthcare market size was approximately USD 194.24 billion in 2024. It is projected to reach around USD 222.61 billion by 2025 and is expected to be worth around USD 644.37 billion by 2034, expanding at a CAGR of 12.74% from 2025 to 2034. Another report estimated the U.S. home healthcare market size at USD 162.35 billion in 2024, with an expectation to reach USD 381.40 billion by 2033, growing at a CAGR of 10.00% from 2025 to 2033.
    • U.S. Hospice Care: The U.S. hospice market size was approximately USD 30.25 billion in 2024 and is projected to reach around USD 47.52 billion by 2034, with a CAGR of 4.62% during the forecast period from 2025 to 2034.
  • Medical Solutions (MS)
    • null

AI Analysis | Feedback

Aveanna Healthcare (AVAH) is anticipated to drive future revenue growth over the next 2-3 years through several key strategies:

  1. Rate Increases and Favorable Reimbursement Environments: Aveanna Healthcare expects continued revenue growth from rate increases, particularly through an improved payer rate environment and successful negotiation of adequate reimbursement rates from payer and government partners. The company anticipates ongoing "wage pass-through" in late 2025 and into 2026, and is targeting double-digit rate wins in 2026, though individual wins are expected to be smaller than in previous years.
  2. Expansion of Preferred Payer Agreements: A significant driver is the expansion of preferred payer agreements across its segments. Aveanna has been actively adding new preferred payer agreements, including five in Q3 2025 alone, and focuses on aligning caregiver capacity with payers offering episodic reimbursement, which has led to positive year-over-year growth and improved outcomes. The company aims to double its number of preferred payers and expand national enteral presence and payer partnerships.
  3. Growth in Patient Volume and Service Utilization: Increased demand for home healthcare services, driven by an aging population and the rising prevalence of chronic diseases, is leading to higher patient volumes and hours of care. Aveanna has seen volume increases in its Private Duty Services and Home Health & Hospice segments, and is optimistic about attracting caregivers to meet this demand when favorable reimbursement rates are secured.
  4. Strategic Acquisitions and Integration: The integration of strategic acquisitions, such as Thrive Skilled Pediatric Care, is contributing to Aveanna's revenue growth. These tuck-in opportunities in key states are part of the company's growth strategy.
  5. Expansion to New Medicaid States: Aveanna is focused on expanding its presence in Medicaid states. The company currently operates in 29 Medicaid states and is targeting expansion to 38-40 states, indicating a strategy to grow its market reach and customer base.

AI Analysis | Feedback

Share Issuance

  • Aveanna Healthcare completed its Initial Public Offering (IPO) in April 2021, generating total net proceeds of $477.6 million. This included the sale of 38.2 million shares at $12.00 per share and an additional 4.0 million shares from the underwriters' overallotment option.
  • In October 2025, the company completed a follow-on equity offering, issuing 10,000,000 shares of common stock for $90 million to increase available capital. [cite: 14 in original search, 16 in original search]

Outbound Investments

  • Aveanna Healthcare acquired Five Points Healthcare for $64.4 million in October 2020.
  • In November 2021, Aveanna acquired Accredited Nursing Care for $180 million.
  • The company acquired Comfort Care Home Health Services, LLC for $346.5 million in December 2021, a transaction financed by a $415 million loan. [cite: 7, 23 in original search]
  • In April 2025, Aveanna acquired Thrive Skilled Pediatric Care for $75 million, which expanded its private duty services offerings and market presence, including new states like Arizona and Kansas.

Capital Expenditures

  • Aveanna Healthcare is investing in digital modernization to upgrade its scheduling, billing, and care coordination systems, aiming to reduce administrative costs and enhance field contribution margins. [cite: 20 in original search]
  • The company is focusing on the modernization of its Medical Solutions division, with this initiative anticipated to drive growth in 2026 and 2027. [cite: 18 in original search]
  • Capitalized expenses decreased in 2023, contributing to a reduction in depreciation and amortization as older assets became fully depreciated.

Better Bets than Aveanna Healthcare (AVAH)

Trade Ideas

Select ideas related to AVAH. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
21.4%21.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.4%-7.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
18.0%18.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.9%3.9%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
12.2%12.2%-5.1%

Recent Active Movers

More From Trefis

Peer Comparisons for Aveanna Healthcare

Peers to compare with:

Financials

AVAHHPQHPEIBMCSCOAAPLMedian
NameAveanna .HP Hewlett .Internat.Cisco Sy.Apple  
Mkt Price8.3622.7324.33305.7477.79273.7651.06
Mkt Cap1.721.432.4285.5307.74,079.8159.0
Rev LTM2,29155,29534,29665,40257,696408,62556,496
Op Inc LTM2353,6241,64411,54412,991130,2147,584
FCF LTM832,80062711,85412,73396,1847,327
FCF 3Y Avg222,9781,40011,75313,879100,5037,366
CFO LTM903,6972,91913,48313,744108,5658,590
CFO 3Y Avg303,6723,89613,49814,736111,5598,697

Growth & Margins

AVAHHPQHPEIBMCSCOAAPLMedian
NameAveanna .HP Hewlett .Internat.Cisco Sy.Apple  
Rev Chg LTM15.5%3.2%13.8%4.5%8.9%6.0%7.4%
Rev Chg 3Y Avg9.5%-3.9%6.5%2.6%3.7%1.8%3.2%
Rev Chg Q22.2%4.2%14.4%9.1%7.5%9.6%9.4%
QoQ Delta Rev Chg LTM5.2%1.1%3.7%2.1%1.8%2.1%2.1%
Op Mgn LTM10.3%6.6%4.8%17.7%22.5%31.9%14.0%
Op Mgn 3Y Avg7.0%7.4%7.2%16.4%24.2%30.8%11.9%
QoQ Delta Op Mgn LTM0.3%-0.2%-1.4%0.6%0.4%0.1%0.2%
CFO/Rev LTM3.9%6.7%8.5%20.6%23.8%26.6%14.6%
CFO/Rev 3Y Avg1.3%6.8%12.7%21.4%26.1%28.4%17.1%
FCF/Rev LTM3.6%5.1%1.8%18.1%22.1%23.5%11.6%
FCF/Rev 3Y Avg0.9%5.5%4.6%18.6%24.6%25.6%12.1%

Valuation

AVAHHPQHPEIBMCSCOAAPLMedian
NameAveanna .HP Hewlett .Internat.Cisco Sy.Apple  
Mkt Cap1.721.432.4285.5307.74,079.8159.0
P/S0.80.40.94.45.310.02.7
P/EBIT7.46.619.725.122.431.321.1
P/E23.18.4569.036.129.841.133.0
P/CFO19.55.811.121.222.437.620.3
Total Yield4.3%14.4%2.3%5.0%5.5%2.8%4.6%
Dividend Yield0.0%2.5%2.1%2.2%2.1%0.4%2.1%
FCF Yield 3Y Avg-1.9%10.6%5.5%6.4%6.0%3.1%5.7%
D/E0.80.50.70.20.10.00.4
Net D/E0.70.30.60.20.00.00.3

Returns

AVAHHPQHPEIBMCSCOAAPLMedian
NameAveanna .HP Hewlett .Internat.Cisco Sy.Apple  
1M Rtn-10.5%-5.8%11.9%-0.9%1.1%-1.8%-1.4%
3M Rtn-5.7%-14.5%1.4%9.9%15.6%7.7%4.5%
6M Rtn59.8%-5.0%20.3%5.0%13.5%33.7%16.9%
12M Rtn79.4%-28.7%15.4%40.8%33.9%7.6%24.6%
3Y Rtn971.8%-5.3%65.8%142.1%78.3%113.9%96.1%
1M Excs Rtn-11.2%-5.5%12.3%-0.5%0.9%-2.7%-1.6%
3M Excs Rtn-9.4%-18.1%-2.3%6.2%11.9%4.0%0.9%
6M Excs Rtn48.6%-16.3%9.0%-6.3%2.2%22.4%5.6%
12M Excs Rtn74.8%-43.3%-0.2%25.4%19.0%-7.8%9.4%
3Y Excs Rtn849.0%-82.8%-10.4%61.9%0.1%27.1%13.6%

Financials

Segment Financials

Revenue by Segment
$ Mil2024202320222021
Private Duty Services (PDS)1,5191,4151,3581,330
Home Health and Hospice (HHH)21923317731
Medical Solutions (MS)158140143134
Total1,8951,7881,6791,495


Price Behavior

Price Behavior
Market Price$8.36 
Market Cap ($ Bil)1.7 
First Trading Date04/29/2021 
Distance from 52W High-18.6% 
   50 Days200 Days
DMA Price$9.08$6.74
DMA Trendupup
Distance from DMA-7.9%24.1%
 3M1YR
Volatility42.3%80.6%
Downside Capture185.8878.54
Upside Capture125.14124.80
Correlation (SPY)45.3%21.5%
AVAH Betas & Captures as of 11/30/2025

 1M2M3M6M1Y3Y
Beta1.881.781.611.640.931.56
Up Beta2.552.522.452.930.621.20
Down Beta1.101.291.302.911.291.95
Up Capture181%194%185%163%142%1615%
Bmk +ve Days12253873141426
Stock +ve Days10223359114351
Down Capture180%168%131%19%92%106%
Bmk -ve Days7162452107323
Stock -ve Days9192661127363

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
null
Based On 5-Year Data
null
Based On 10-Year Data
null

Short Interest

Short Interest: As Of Date12152025
Short Interest: Shares Quantity3,619,836
Short Interest: % Change Since 113020253.8%
Average Daily Volume1,022,643
Days-to-Cover Short Interest3.54
Basic Shares Quantity208,948,000
Short % of Basic Shares1.7%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/21/2025-7.4%-4.1%-17.4%
8/7/202549.4%83.8%111.3%
3/13/202537.4%47.3%28.3%
11/7/202416.2%19.3%11.4%
8/8/202432.2%33.5%58.0%
3/14/2024-3.0%-2.4%-6.4%
11/9/20232.0%27.9%75.8%
3/16/2023-6.7%-33.2%-16.1%
...
SUMMARY STATS   
# Positive766
# Negative788
Median Positive16.2%30.7%43.2%
Median Negative-7.6%-17.8%-17.5%
Max Positive49.4%83.8%111.3%
Max Negative-26.7%-38.0%-44.0%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202511/06/202510-Q (09/30/2025)
06/30/202508/07/202510-Q (06/30/2025)
03/31/202505/08/202510-Q (03/31/2025)
12/31/202403/13/202510-K (12/31/2024)
09/30/202411/07/202410-Q (09/30/2024)
06/30/202408/08/202410-Q (06/30/2024)
03/31/202405/09/202410-Q (03/31/2024)
12/31/202303/14/202410-K (12/31/2023)
09/30/202311/09/202310-Q (09/30/2023)
06/30/202308/10/202310-Q (06/30/2023)
03/31/202305/11/202310-Q (03/31/2023)
12/31/202203/16/202310-K (12/31/2022)
09/30/202211/15/202210-Q (09/30/2022)
06/30/202208/11/202210-Q (06/30/2022)
03/31/202205/11/202210-Q (03/31/2022)
12/31/202103/28/202210-K (12/31/2021)

Insider Activity

Expand for More
 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0VIGANO PAUL R 10282025Sell9.001,251,90911,267,181173,635,083Form
1J.H. Whitney Equity Partners VII, LLC 10282025Sell9.001,251,90911,267,181173,635,083Form
2WILLIAMS ROBERT M JR 10282025Sell9.001,251,90911,267,181173,635,083Form
3WILLIAMS ROBERT M JR 10232025Sell9.008,346,05975,114,531184,902,264Form
4VIGANO PAUL R 10232025Sell9.008,346,05975,114,531184,902,264Form